DK1479394T3 - Anvendelse af epidermal vækstfaktor (EGF) til ögning af vækstforögelse hos et dyr - Google Patents

Anvendelse af epidermal vækstfaktor (EGF) til ögning af vækstforögelse hos et dyr

Info

Publication number
DK1479394T3
DK1479394T3 DK04019831T DK04019831T DK1479394T3 DK 1479394 T3 DK1479394 T3 DK 1479394T3 DK 04019831 T DK04019831 T DK 04019831T DK 04019831 T DK04019831 T DK 04019831T DK 1479394 T3 DK1479394 T3 DK 1479394T3
Authority
DK
Denmark
Prior art keywords
egf
animal
growth factor
increase
epidermal growth
Prior art date
Application number
DK04019831T
Other languages
English (en)
Inventor
Andre G Buret
D Grant Gall
James A Hardin
Merle E Olson
Original Assignee
Univ Technologies Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Technologies Int filed Critical Univ Technologies Int
Application granted granted Critical
Publication of DK1479394T3 publication Critical patent/DK1479394T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles
    • A61K31/277Nitriles; Isonitriles having a ring, e.g. verapamil
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/142Amino acids; Derivatives thereof
    • A23K20/147Polymeric derivatives, e.g. peptides or proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/168Steroids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/184Hormones
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/30Feeding-stuffs specially adapted for particular animals for swines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1808Epidermal growth factor [EGF] urogastrone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Birds (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Obesity (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK04019831T 1995-05-10 1996-05-09 Anvendelse af epidermal vækstfaktor (EGF) til ögning af vækstforögelse hos et dyr DK1479394T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/438,901 US5753622A (en) 1995-05-10 1995-05-10 Use of epidermal growth factor as a gastrointestinal therapeutic agent
PCT/CA1996/000291 WO1996035445A1 (en) 1995-05-10 1996-05-09 The use of epidermal growth factor as a gastrointestinal therapeutic agent

Publications (1)

Publication Number Publication Date
DK1479394T3 true DK1479394T3 (da) 2007-06-11

Family

ID=23742496

Family Applications (3)

Application Number Title Priority Date Filing Date
DK04019831T DK1479394T3 (da) 1995-05-10 1996-05-09 Anvendelse af epidermal vækstfaktor (EGF) til ögning af vækstforögelse hos et dyr
DK96913397T DK0824357T3 (da) 1995-05-10 1996-05-09 Anvendelsen af epidermal vækstfaktor som et gastrointestinalt terapeutisk middel
DK00123426T DK1092437T3 (da) 1995-05-10 1996-05-09 Anvendelse af epidermal vækstfaktor som et gastrointestinalt terapeutisk middel

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK96913397T DK0824357T3 (da) 1995-05-10 1996-05-09 Anvendelsen af epidermal vækstfaktor som et gastrointestinalt terapeutisk middel
DK00123426T DK1092437T3 (da) 1995-05-10 1996-05-09 Anvendelse af epidermal vækstfaktor som et gastrointestinalt terapeutisk middel

Country Status (12)

Country Link
US (2) US5753622A (da)
EP (3) EP0824357B1 (da)
JP (1) JP3549541B2 (da)
AT (3) ATE357927T1 (da)
AU (1) AU704675B2 (da)
CA (2) CA2492724C (da)
DE (3) DE69614377T2 (da)
DK (3) DK1479394T3 (da)
ES (2) ES2285320T3 (da)
NZ (2) NZ307134A (da)
PT (1) PT1479394E (da)
WO (1) WO1996035445A1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753622A (en) * 1995-05-10 1998-05-19 University Technologies International, Inc. Use of epidermal growth factor as a gastrointestinal therapeutic agent
US6313103B1 (en) 1998-05-13 2001-11-06 Carrington Laboratories, Inc. Pectic substance as a growth factor stabilizer
US5929051A (en) * 1998-05-13 1999-07-27 Carrington Laboratories, Inc. Aloe pectins
US7022683B1 (en) * 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
US20060014684A1 (en) * 2000-03-03 2006-01-19 University Technologies International Inc. Novel uses of EGF
US7494669B2 (en) 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
JP2004536589A (ja) * 2001-05-18 2004-12-09 カナダ国 ウシ上皮成長因子の核酸及びタンパク質配列
JP2005507919A (ja) * 2001-10-26 2005-03-24 ユニヴァーシティ・テクノロジーズ・インターナショナル・インコーポレーテッド 泌尿生殖器経路の病原感染を阻害するためのegfの使用
CA2427190A1 (en) * 2002-04-30 2003-10-30 Alberta Research Council Inc. Production of recombinant epidermal growth factor in plants
WO2004001020A2 (en) * 2002-06-19 2003-12-31 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Methods and means to promote gut absorption
CA2582958A1 (en) * 2004-09-30 2006-04-06 University Technologies International Inc. Rehydration compositions comprising epidermal growth factor
US8703769B2 (en) * 2005-07-15 2014-04-22 The University Of North Carolina At Chapel Hill Use of EGFR inhibitors to prevent or treat obesity
AU2006319216B2 (en) 2005-11-29 2012-09-13 Intrexon Actobiotics Nv Induction of mucosal tolerance to antigens
EP3351268B1 (en) 2007-01-25 2020-08-05 Intrexon Actobiotics NV Treatment of immune disease by mucosal delivery of antigens
WO2010042821A1 (en) * 2008-10-10 2010-04-15 Nationwide Children's Hospital Method of treating necrotizing enterocolitis using heparin binding epidermal growth factor
CN102696887B (zh) * 2012-06-20 2013-07-31 湖南海谷生物技术有限公司 一种具有营养保健促生长功能的饲料活性蛋粉及其生产方法
US11241480B2 (en) * 2017-01-26 2022-02-08 Washington University Methods for modulation of dietary and microbial exposure with compositions comprising an EGFR ligand
CN113813369B (zh) * 2021-11-09 2023-09-22 浙江省农业科学院 用于预防/治疗仔猪肠道损伤的egf/mmt复合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8409960D0 (en) * 1984-04-17 1984-05-31 Searle & Co Therapeutic method
DE3781682T2 (de) * 1986-12-11 1993-01-21 British Tech Group Verbesserungen im gebrauch oder in bezug auf den gebrauch von egf.
DK0577903T3 (da) 1992-07-06 1998-04-06 Nestle Sa Antigastritisk middel
US5753622A (en) * 1995-05-10 1998-05-19 University Technologies International, Inc. Use of epidermal growth factor as a gastrointestinal therapeutic agent

Also Published As

Publication number Publication date
ATE203912T1 (de) 2001-08-15
NZ307134A (en) 2000-02-28
AU704675B2 (en) 1999-04-29
EP1479394B1 (en) 2007-03-28
CA2220434C (en) 2005-02-22
DE69637002D1 (de) 2007-05-10
DE69614377D1 (de) 2001-09-13
HK1072894A1 (en) 2005-09-16
EP1092437A1 (en) 2001-04-18
DE69633583D1 (de) 2004-11-11
ES2285320T3 (es) 2007-11-16
AU5641196A (en) 1996-11-29
ATE357927T1 (de) 2007-04-15
EP0824357B1 (en) 2001-08-08
EP1479394A1 (en) 2004-11-24
PT1479394E (pt) 2007-04-30
NZ501482A (en) 2004-12-24
CA2220434A1 (en) 1996-11-14
DE69614377T2 (de) 2002-05-23
EP1092437B1 (en) 2004-10-06
JPH11505528A (ja) 1999-05-21
DE69633583T2 (de) 2006-02-23
JP3549541B2 (ja) 2004-08-04
DK0824357T3 (da) 2001-10-08
DE69637002T2 (de) 2007-08-16
CA2492724A1 (en) 1996-11-14
DK1092437T3 (da) 2005-01-31
EP0824357A1 (en) 1998-02-25
US5753622A (en) 1998-05-19
WO1996035445A1 (en) 1996-11-14
ATE278415T1 (de) 2004-10-15
US6656907B1 (en) 2003-12-02
ES2226681T3 (es) 2005-04-01
CA2492724C (en) 2010-08-03

Similar Documents

Publication Publication Date Title
DK1092437T3 (da) Anvendelse af epidermal vækstfaktor som et gastrointestinalt terapeutisk middel
ATE95060T1 (de) Verwendung von c-22 bis c-26-aliphatischen alkoholen zur behandlung entzuendlicher und viraler hauterkrankungen.
NO933525D0 (no) Xylanase, tilsvarende rekombinant dna-sekvens, xylanaseholding middel og anvendelse av middelet
AU2118488A (en) Improvements in or relating to methods of treating damaged skin
ATE184289T1 (de) Ribosomen-inaktivierende proteine, inaktive vorläuferformen derselben, verfahren zur herstellung und eine methode zur nutzung
ATE225176T1 (de) Verwendung von serotonin-antagonisten (5ht3) zur behandlung von fibromyalgie
DE69224124D1 (de) Verfahren zur Herstellung von Dihomo-Gamma-Linolensäure und das in dieser enthaltende Lipid
DE59712094D1 (de) Mittel zur herstellung von aquarien- und gartenteichwasser und verwendung davon
DE69001573D1 (de) Zusammensetzungen zur herstellung von in dosisformen aktiven vitaminen d3 sowie verfahren zur herstellung stabiler, in dosisformen aktiver vitamine d3 unter deren verwendung.
DE3778089D1 (de) Verfahren zur herstellung und verwendung fester, pflanzenwirksamer zusammensetzungen.
YU78092A (sh) Postupak za dobijanje derivata beta-fenilizoserina i njihova primena
ATE178206T1 (de) Verfahren zur vorbeugung und behandlung von durch chemotherapie ausgelöster alopezie
ATE83480T1 (de) Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen.
DE68905657D1 (de) Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen.
DE3686097D1 (de) Verwendung von dopamin-agonisten zur herstellung eines arzneimittels zur behandlung von psychostimulant-sucht.
ATE234613T1 (de) Verwendung von comt inhibitoren zur herstellung eines arzneimittels zur vorbeugung von diabetischen vaskulären funktionsstörungen
DE68914660D1 (de) Verfahren zur Herstellung von den Safranblütennarben ähnlichem Gewebe sowie Verfahren zur Herstellung von nützlichen Stoffen aus safranblütennarbenähnlichem Gewebe.
JPS5729270A (en) Preparation of nonheat-coagulable egg white
ATE84295T1 (de) Verfahren zur herstellung von 2,6,6-trimethylcyclohex-2-en-1,4-dion.
DE69109953D1 (de) Alfa-fluorocarbonsäurederivate als Zwischenprodukte zur Herstellung von Fungiziden.
IL107242A0 (en) Derivatives of benzeneborinic acid, preparation thereof and use thereof as synthetic intermediates
MY108436A (en) Feed and method for promoting or improving the growth of animals
AU2719488A (en) Method for supplying an oblong plant trough with end walls and apparatus for carrying out the method
BG60542B2 (en) Water soluble composition having coccidiostatic effect
CA2031825A1 (en) Bath additive and its use